GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Yale Endowment Fund Loads Up EEM

10qk

Yale Endowment Fund just reported its first quarter portfolio. The fund is managed by David Swensen, who has built his fame for the outstanding performances of the fund. The fund buys Ishares MSCI Emerging Market Income ETF, Dionex Corp., Approach Resources Inc., sells Theravance Inc., The Goldman Sachs Group Inc., Genomic Health Inc., Savvis Inc. during the 3-months ended 03/31/2011, according to the most recent filings of his investment company, Yale University. As of 03/31/2011, Yale Endowment Fund owns 7 stocks with a total value of $117 million. These are the details of the buys and sells.

This is the portfolio chart of David Swensen. You can click on the legend of the chart to show/hide buys, sells, or holdings. Each ball on the chart represents a position in the portfolio. You can move your mouse on the balls to see the details of each position and click to see the details of all guru trades with this position.



For the details of David Swensen's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=David+Swensen

This is the sector weightings of his portfolio:

Industrials 2.6%
Oil & Gas 2.2%
Consumer Goods 0.7%


These are the top 5 holdings of David Swensen

  1. IShares MSCI Emerging Market Income ETF (EEM) - 1,242,916 shares, 51.49% of the total portfolio. Shares added by 91.83%
  2. SPDR S&P 500 ETF TRUST (SPY) - 277,000 shares, 31.24% of the total portfolio.
  3. IShares S&P 100 Index Fund (OEF) - 127,000 shares, 6.42% of the total portfolio.
  4. IShares Trust MSCI EAFE Index Fund (EFA) - 106,000 shares, 5.42% of the total portfolio.
  5. Dionex Corp. (DNEX) - 25,532 shares, 2.57% of the total portfolio. Shares added by 10000%


Added: Ishares MSCI Emerging Market Income ETF (EEM)

David Swensen added to his holdings in Ishares Msci Emerging Market Income Etf by 91.83%. His purchase prices were between $44.6 and $48.32, with an estimated average price of $46.55. The impact to his portfolio due to this purchase was 24.65%. His holdings were 1,242,916 shares as of 03/31/2011.

New Purchase: Dionex Corp. (DNEX)

David Swensen initiated holdings in Dionex Corp.. His purchase prices were between $117.48 and $118.15, with an estimated average price of $117.83. The impact to his portfolio due to this purchase was 2.57%. His holdings were 25,532 shares as of 03/31/2011.

Dionex Corporation designs, manufactures, markets and services analytical instrumentation and related accessories and chemicals. Dionex Corp. has a market cap of $2.07 billion; its shares were traded at around $118.48 with a P/E ratio of 34.7 and P/S ratio of 4.9. Dionex Corp. had an annual average earnings growth of 12% over the past 10 years. GuruFocus rated Dionex Corp. the business predictability rank of 5-star.

New Purchase: Approach Resources Inc. (AREX)

David Swensen initiated holdings in Approach Resources Inc.. His purchase prices were between $23.1 and $32.55, with an estimated average price of $28.08. The impact to his portfolio due to this purchase was 2.2%. His holdings were 77,120 shares as of 03/31/2011.

Approach Resources Inc. is an independent energy company engaged in the exploration, development, exploitation, production and acquisition of unconventional natural gas and oil properties onshore in the United States and Western Canada. Approach Resources Inc. has a market cap of $676.4 million; its shares were traded at around $23.79 with a P/E ratio of 58 and P/S ratio of 11.7.

Sold Out: Theravance Inc. (THRX)

David Swensen sold out his holdings in Theravance Inc.. His sale prices were between $20.98 and $25.78, with an estimated average price of $23.32.

Theravance Inc is focused on the discovery, development and commercialization of small molecule medicines for unmet medical needs across a number of therapeutic areas including respiratory disease, bacterial infections, overactive bladder and gastrointestinal disorders. Theravance Inc. has a market cap of $2.17 billion; its shares were traded at around $26.22 with and P/S ratio of 89.6.

Sold Out: The Goldman Sachs Group Inc. (GS)

David Swensen sold out his holdings in The Goldman Sachs Group Inc.. His sale prices were between $154.38 and $175, with an estimated average price of $164.5.

Goldman Sachs is a global investment banking and securities firm, providing a full range of investing, advisory and financing services worldwide to a substantial and diversified client base, which includes corporations, financial institutions, governments, and high net worth individuals. The Goldman Sachs Group Inc. has a market cap of $74.3 billion; its shares were traded at around $142.75 with a P/E ratio of 12.9 and P/S ratio of 1.9. The dividend yield of The Goldman Sachs Group Inc. stocks is 0.9%. The Goldman Sachs Group Inc. had an annual average earnings growth of 9.8% over the past 10 years.

Sold Out: Genomic Health Inc. (GHDX)

David Swensen sold out his holdings in Genomic Health Inc.. His sale prices were between $21.08 and $26.18, with an estimated average price of $23.29.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. Genomic Health Inc. has a market cap of $786.8 million; its shares were traded at around $27.02 with a P/E ratio of 135.2 and P/S ratio of 4.4.

Sold Out: Savvis Inc. (SVVS)

David Swensen sold out his holdings in Savvis Inc.. His sale prices were between $25.52 and $37.02, with an estimated average price of $31.85.

SAVVIS Inc is a global IT utility services provider that focuses exclusively on IT solutions for businesses. Savvis Inc. has a market cap of $2.24 billion; its shares were traded at around $39.25 with and P/S ratio of 2.4.


Rating: 2.8/5 (11 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK